Fleury SA
BOVESPA:FLRY3

Watchlist Manager
Fleury SA Logo
Fleury SA
BOVESPA:FLRY3
Watchlist
Price: 13.58 BRL 0.82% Market Closed
Market Cap: 7.4B BRL
Have any thoughts about
Fleury SA?
Write Note

Net Margin
Fleury SA

8.1%
Current
8%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.1%
=
Net Income
613.5m
/
Revenue
7.5B

Net Margin Across Competitors

Country BR
Market Cap 7.4B BRL
Net Margin
8%
Country US
Market Cap 91.8B USD
Net Margin
1%
Country US
Market Cap 87.7B EUR
Net Margin
1%
Country US
Market Cap 73B USD
Net Margin
1%
Country DE
Market Cap 24.9B EUR
Net Margin
3%
Country US
Market Cap 20.1B USD
Net Margin
3%
Country DE
Market Cap 18.8B EUR
Net Margin
-2%
Country US
Market Cap 18.3B USD
Net Margin
9%
Country US
Market Cap 13.7B USD
Net Margin
7%
Country DE
Market Cap 12.4B EUR
Net Margin
3%
Country AU
Market Cap 13.4B AUD
Net Margin
6%
No Stocks Found

Fleury SA
Glance View

Market Cap
7.4B BRL
Industry
Health Care

Fleury SA engaged in the provision of medical diagnostic services. The company is headquartered in Sao Paulo, Sao Paulo and currently employs 20,800 full-time employees. The company went IPO on 2009-12-16. The Company’s activities are divided into three business lines: Patient Service Centers (PSC), B2B and Dental Diagnosis. The PCS division offers private medical diagnostics. The B2B division is responsible for clinical analysis and diagnostic imaging in partner hospitals, as well as tests for laboratories, hospitals and clinics throughout Brazil. The Dental Diagnosis division provides dental diagnostic imaging through Papaiz Associados Diagnosticos por Imagem SA, a joint venture with Odontoprev SA. The firm operates through several brands, such as Fleury Medicina e Saude, Clinica Felippe Mattoso e Weinmann, a+ Medicina Diagnostica, Diagnoson a+, Diagmax and Inlab, among others.

FLRY3 Intrinsic Value
20.02 BRL
Undervaluation 32%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
8.1%
=
Net Income
613.5m
/
Revenue
7.5B
What is the Net Margin of Fleury SA?

Based on Fleury SA's most recent financial statements, the company has Net Margin of 8.1%.